Expansion of the S–CN-DABO scaffold to exploit the impact on inhibitory activities against the non-nucleoside HIV-1 reverse transcriptase-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expansion of the S–CN-DABO scaffold to exploit the impact on inhibitory activities against the non-nucleoside HIV-1 reverse transcriptase

Published:2022-08 Issue: Volume:238 Page:114512
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Ling Xu,Hao Qing-Qing,Pannecouque Christophe,Clercq Erik De,Chen Fen-Er

Funder

National Natural Science Foundation of China

Ningxia Medical University

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference60 articles.

1. Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years;Zhuang;Acta Pharm. Sin. B,2020

2. Approved antiviral drugs over the past 50 years;De Clercq;Clin. Microbiol. Rev.,2016

3. Recent Advances in the DABOs family as potent HIV-1 non-nucleoside reverse transcriptase inhibitors;Yu;Curr. Med. Chem.,2011

4. Anti-HIV drug discovery and development: current innovations and future trends;Zhan;J. Med. Chem.,2016

5. HIV drug development: the next 25 years;Flexner;Nat. Rev. Drug Discov.,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the enigmas of non‐nucleoside reverse transcriptase inhibitors (NNRTIs): A medicinal chemistry expedition towards combating HIV drug resistance;Medicinal Research Reviews;2024-08-26

2. Design of novel DABO derivatives as HIV-1 RT inhibitors using molecular docking, molecular dynamics simulations and ADMET properties;Journal of Biomolecular Structure and Dynamics;2023-06-05

3. Development of novel S-N3-DABO derivatives as potent non-nucleoside reverse transcriptase inhibitors with improved potency and selectivity;European Journal of Medicinal Chemistry;2023-02

4. Structure-guided design of novel HEPT analogs with enhanced potency and safety: From Isopropyl-HEPTs to Cyclopropyl-HEPTs;European Journal of Medicinal Chemistry;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3